Trials / Conditions / Acute HIV Infection

Acute HIV Infection

22 registered clinical trials studyying Acute HIV Infection — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV NCT06484335	Henry M. Jackson Foundation for the Advancement of Military Medicine	Phase 1
Recruiting	A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Init NCT05719441	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Unknown	Empiric Treatment for Acute HIV in the ED NCT03711253	University of Southern California	Phase 4
Completed	Specimen Repository for HIV Immunopathogenesis NCT03579381	AIDS Healthcare Foundation	—
Completed	Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretro NCT02614950	SEARCH Research Foundation	N/A
Completed	Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV NCT02384395	University of North Carolina, Chapel Hill	N/A
Recruiting	Netherlands Cohort Study on Acute HIV Infection NCT05728996	Prof. Jan Prins	—
Completed	Acute Partner and Social Contact Referral: iKnow NCT02467439	University of North Carolina, Chapel Hill	N/A
Completed	Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection NCT02170246	Yale University	Phase 1
Completed	Assessment of the HIV CNS Reservoir, Neurological and Neuro-cognitive Effects, and Source of Rebound HIV in CN NCT02470351	SEARCH Research Foundation	—
Completed	Efficacy of VHM After Treatment Interruption in Subjects Initiating ART During Acute HIV Infection NCT02475915	SEARCH Research Foundation	Phase 1 / Phase 2
Completed	Using Telmisartan With ART During Acute HIV Infection to Reduce the CNS Reservoirs of HIV and Lymph Node Fibro NCT02750059	SEARCH Research Foundation	Phase 2
Unknown	Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The NCT02231281	Yongtao Sun, MD, PhD	Phase 3
Completed	Effects of Intensive cART During Acute/Early HIV Infection NCT01154673	University of Toronto	Phase 2 / Phase 3
Completed	Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection NCT01434706	University of California, San Diego	N/A
Completed	HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence NCT01369056	University of Tartu	N/A
Completed	Feasibility and Acceptability Study of an Individual-Level Behavioral Intervention for Individuals With Acute NCT01197027	HIV Prevention Trials Network	Phase 3
Recruiting	Antiretroviral Therapy for Acute and Chronic HIV Infection NCT00796263	SEARCH Research Foundation	Phase 3
Recruiting	Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population NCT00796146	SEARCH Research Foundation	—
Terminated	HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine NCT00855413	University of North Carolina, Chapel Hill	Phase 4
Completed	Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection NCT00734344	University of Alabama at Birmingham	N/A
Completed	Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805) NCT00924898	University of North Carolina, Chapel Hill	Phase 4